Table 3.
Demographic and clinical characteristics of sickle cell children at 12 months of follow-up, before the implementation of sickle cell management recommendations (n = 143)
Variable | Median (IQR 25–75%) | n | % |
---|---|---|---|
Age | 10 (IQR: 6–15 years) | ||
Age at diagnosis | 2 (IQR: 1–5 years) | ||
Before 1 year | 53 | 37 | |
Between 1 and 5 years old | 55 | 39 | |
Between 5 and 10 years old | 22 | 15 | |
After 10 years | 13 | 9 | |
Sex | Female | 62 | 43 |
Schooling | Yes | 99 | 69 |
Z-score weight-for-height less than −2SD | Yes | 67 | 47 |
Mode of the first diagnosis | Clinical | 62 | 43 |
Electrophoresis of Hb | 44 | 31 | |
Emmel test | 37 | 26 | |
Circumstances of the first diagnosis | Vaso-occlusive crisis | 94 | 66 |
Anemia | 25 | 18 | |
Screening at the time of inclusion | 14 | 10 | |
Fever | 8 | 6 | |
Jaundice | 2 | 1 | |
Neonatal screening | 0 | 0 | |
Confirmation of diagnosis by isoelectrofocusing | Yes | 143 | 100 |
Chronic complications | Yes | 31 | 22 |
Type of complications | Hip arthritis | 13 | 11 |
Stroke | 7 | 5 | |
Right eye blindness | 1 | 1 | |
Osteomyelitis | 4 | 3 | |
Leg ulcer | 3 | 2 | |
Other | 3 | 2 | |
Reasons for hospitalizations | Vaso-occlusive crisis | 45 | 31 |
Infectious episodes | 34 | 24 | |
Anemia/blood transfusion | 24 | 17 | |
Other causes | 40 | 28 | |
Presence of hepatomegaly | Yes | 86 | 60 |
Presence of jaundice | Yes | 126 | 88 |
Presence of splenomegaly | Yes | 98 | 69 |
Spleen measurement (according to Hackett’s grade) | H0 | 45 | 31 |
H1 | 16 | 11 | |
H2 | 34 | 24 | |
H3 | 24 | 17 | |
H4 | 15 | 10 | |
H5 | 9 | 6 |
IQR interquartile range, Hackett’s grade H0, non-palpable spleen, even in deep inspiration, H1 Spleen palpable only on deep inspiration, H2 Spleen palpable on mid-clavicular line, halfway between umbilicus and costal margin, H3 The spleen expands towards the umbilicus, h4 spleen descending below the navel, exceeding the line passing between the umbilicus and the pubic symphysis, H5 spleen extending lower than class H4